MoneyWorks4Me

Dr Reddys Laboratories informs about press release

12 May 2021 Evaluate
Dr Reddys Laboratories has informed that it has enclosed a Press Release on ‘Dr. Reddy's Laboratories enters into a Voluntary Licensing Agreement with Lilly to Expand Access to Covid-19 Treatment in India.’

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1801.00
Dr. Reddys Labs. 1209.15
Cipla 1343.00
Lupin 2035.00
Zydus Lifesciences 1160.00
View more..